Studies on the mechanism of vaccinal immunity to Marek''s disease

Current knowledge of the nature of the antigens and of the host immune responses in vaccinal immunity to Marek's disease is reviewed. It is suggested that a two-step mechanism of resistance operates. The first step involves humoral and cell-mediated responses directed against viral antigens; the second step occurs after challenge with Marek's disease virus and consists of cellmediated responses directed against tumour cells.     

Adjuvants in veterinary vaccines: modes of action and adverse effects

Vaccine adjuvants are chemicals, microbial components, or mammalian proteins that enhance the immune response to vaccine antigens. Interest in reducing vaccine-related adverse effects and inducing specific types of immunity has led to the development of numerous new adjuvants. Adjuvants in development or in experimental and commercial vaccines include aluminum salts (alum), oil emulsions, saponins, immune-stimulating complexes (ISCOMs), liposomes, microparticles, nonionic block copolymers, derivatized polysaccharides, cytokines, and a wide variety of bacterial derivatives. The mechanisms of action of these diverse compounds vary, as does their induction of cell-mediated and antibody responses. Factors influencing the selection of an adjuvant include animal species, specific pathogen, vaccine antigen, route of immunization, and type of immunity needed.     

Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection

The studies reviewed here evaluated the role cellular immune system components play in control of brucellosis by conducting comparative studies with brucella-resistant C57BL/10 or C57BL/6 mice and susceptible BALB/c mice. We have shown by both in vitro and in vivo studies that activation of macrophages with interferon-gamma (IFN-γ) is an important factor for control of infection with B. abortus in the mouse model and that the mechanism of anti-brucella activity largely involved reactive oxygen intermediates. Differences in control of the organism by resistant and susceptible mice was not related to inherent differences in the ability of their macrophages to control infection either with or without IFN-γ activation nor was it attributable to NK cells since we found no role for them in control of brucellosis in either mouse strain. However, relative resistance to brucellosis did correlate with increased production of IFN-γ by CD4 T cells during the first weeks after infection while IL-10 contributed to susceptibility in BALB/c mice. Moreover, by 3 weeks post-infection splenocytes from the susceptible BALB/c mice failed to produce IFN-γ and relied on TNF- as well as CD8 T cells to control infection until the end of the plateau phase around 6 weeks post-infection when IFN-γ production resumed and clearance began. In contrast, IFN-γ was crucial for control throughout the infection in the more resistant C57BL/6 mice and the mice died in its absence by 6 weeks post-infection compared to 12 weeks for the more susceptible mice that relied on additional mechanisms of control. In contrast to the IFN-γ knock-out mice, both β2 microglobulin knock-out C57BL/6 mice, which do not express conventional MHC class I molecules and thus cannot present antigen to CD8 T cells, or perforin knock-out C57BL/6 mice, which have no T cell cytotoxic activity, controlled and cleared the infection as well as normal C57BL/6 mice. The hiatus of IFN-γ production in BALB/c mice correlated with very high levels of total IL-12 and it was postulated that the lack of IFN-γ was a consequence of p40 homodimer blocking activity. However, reduction of p40 IL-12 in vivo through administration of indomethacin reduced the infection without a concomitant measurable increase in IFN-γ. Current studies are aimed at elucidating the mechanism of the IFN-γ hiatus.     

Anticoccidial Vaccination of Broiler Chickens in Various Management Programmes: Relationship between Oocyst Accumulation in Litter and the Development of Protective Immunity

Paracox anticoccidial vaccine was administered to a 7-day-old flock of commercial broiler breeder stock subsequently reared to point-of-lay in the same house. For comparison, three subgroups of another flock of broiler breeders were also vaccinated with Paracox at 7 days of age, reared to 42 days and then transferred to new litter on another farm until point-of-lay. The first subgroup received no further treatment, but the second and third each received a second vaccination with Paracox, either immediately after transfer to the new litter or 42 days after transfer. Using an Eimeria necatrix model, protective immunity was demonstrated by virulent challenge of samples of birds from all groups by the age of 37–40 days (30–33 days after the first vaccination), and was maintained to at least 122–125 days of age, whether the birds remained on the same litter or were transferred to another farm, and whether they received one or two anticoccidial vaccinations. Therefore, there is no disadvantage in transferring birds onto new litter 35 days after a single Paracox vaccination, nor is there any advantage in giving a second vaccination after such a transfer. Vaccinated birds seeded the new litter with oocysts, despite being clinically immune to coccidiosis. A supplementary laboratory experiment showed that birds vaccinated at 8 days of age passed almost no oocysts after a second vaccination at 43 days of age. This indicated that they were not only protected against clinical coccidiosis, but were almost solidly immune to a homologous infection 5 weeks after a single vaccination. Nevertheless, oocysts appeared in the litter of all four groups of commercial breeders throughout the trial, showing that wild-type heterologous infections occurred whether the birds were transferred to new litter or not, but these did not overwhelm the acquired protective immunity and cause clinical coccidiosis.     

中药对畜禽免疫功能影响的研究进展

文章综述了中药对畜禽免疫器官重量、单核-巨噬细胞系统功能、特异性免疫功能、细胞因子等的影响,阐述了中药调节畜禽免疫功能的机理.     

黄芪多糖对人工感染IBDV雏鸡红细胞免疫功能的影响

将由未免疫接种腔上囊病疫苗鸡的种蛋孵化而来的160只1日龄海兰白雏鸡随机分为A、B、C和D共4组。A组为对照组，B、C和D组于26日龄时按每只0．3mL的剂量用IBDV攻毒。A、B组未用黄芪多糖（APS）处理，C、D组从攻毒当日起连续胸肌注射APS6d，剂量分别为每只鸡5mg和10mg。分别在21、29、32、35、38日龄时心脏采血1～3mL，测定E—C3bRR、E—ICRR、ERER和ERIR。结果显示，雏鸡感染IBDV后可使E-C3bRR和ERER显著降低（P〈0．01）；APS处理组E-C3bRR、E-ICRR、ERER均高于A、B组（P〈0．01），其中D组最高，而ERIR则与A组相似。证实，雏鸡感染IBDV后红细胞免疫功能低下，而APS可显著提高其红细胞免疫功能。     

牛病毒性腹泻病毒持续感染的免疫学研究进展

牛病毒性腹泻病毒(BVDV)是危害养牛业的重要病原之一。BVDV感染能够引起广泛的临床症状,包括牛病毒性腹泻-黏膜病、持续感染、免疫耐受、繁殖障碍、血小板减少与出血综合征等。由于其病原的复杂性,给该病的控制及疫苗研制带来了一定的困难。近年来,对其免疫学的研究取得了一定进展,特别是在病原的基本免疫学特征、体液免疫、细胞免疫、免疫耐受和免疫调节方面做了深入研究,同时也在参与免疫应答的细胞因子方面做了研究,这些都为牛病毒性腹泻-黏膜病的预防和控制研究提供了新的思路。     

共轭亚油酸对动物免疫功能的调节

共轭亚油酸具有广泛的生物学功能,它对增加机体免疫球蛋白含量,促进免疫细胞增殖、细胞因子产生、吞噬细胞的功能,基因表达都具有调节作用。本文就共轭亚油酸的免疫调节作用进行了阐述。     

饲料中维生素A水平对凡纳滨对虾生长、饲料利用、体组成成分及非特异性免疫反应的影响

本文旨在研究5种等氮等能饲料中,维生素A添加水平对凡纳滨对虾(Penaeus vannameiBoone)生长、饲料利用、体组成成分及非特异性免疫反应的影响。试验选用平均初始体重为(0.069±0.005)g的凡纳滨对虾450尾,随机分为5个处理组,每组90尾,每组设3个重复,每个重复30尾。试验采用单因素设计,以维生素A醋酸酯为维生素A源,用添加不同水平维生素A(添加量分别为0、18、365、4和72 mg/kg)的饲料喂养凡纳滨对虾,试验期11周。结果表明:在养殖前4周,饲料中添加维生素A显著促进凡纳滨对虾的生长(P<0.05),提高其对饲料利用效率(P<0.05),而对对虾的成活率不产生显著的影响(P>0.05);第11周的结果表明,饲料中添加维生素A并不能显著影响凡纳滨对虾的生长、饲料利用效率和成活率(P>0.05)。维生素A对对虾体脂肪、蛋白质含量的影响显著(P<0.05),对对虾体水分和灰分含量无显著影响(P>0.05)。维生素A对对虾血清中溶菌酶活力、酚氧化酶活力和血液红细胞数量的影响显著(P<0.05),饲料中未添加维生素A或过量添加(超过36 mg/kg)均导致血清中溶菌酶活力、酚氧化酶活力和血细胞总数显著下降(P<0.0 5),而对血清超氧化物歧化酶活力无显著影响(P>0.0 5)。用折线回归模型分析饲料维生素A添加量与对虾增重率的变化关系,表明在试验前4周,凡纳滨对虾饲料中维生素A的适宜添加量为2 2.5 0 mg/kg;1 1周试验期间,凡纳滨对虾饲料中维生素A适宜添加量为1 8 mg/kg;以溶菌酶、酚氧化酶活力为指标,凡纳滨对虾饲料中维生素A最适添加量为5 9.5 1 mg/kg。     

不同佐剂新城疫疫苗对鸡体液免疫的影响

佐剂是疫苗研究的重要组成部分.选择合适的佐剂不仅可以增强疫苗的免疫效果,而且可以提高机体的抵抗力.不同佐剂对体液免疫会产生不同的作用.本研究选用白油佐剂、弗氏佐剂和蜂胶佐荆与新城疫病毒抗原混合制成疫苗,免疫雏鸡,探讨不同佐剂对鸡体液免疫的影响.结果表明,三种佐剂疫苗均有保护力,试验鸡饲养至61日龄均未发生新城疫,其中弗氏佐剂的效果最好,蜂胶佐剂的效果次之,油佐剂组检测到雏鸡61日龄时仍未出现抗体高峰值.